BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32513667)

  • 21. SUBRETINAL NEOVASCULARIZATION IN MACULAR TELANGIECTASIA TYPE 2: OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY AND TREATMENT RESPONSE.
    Tan GS; Kuehlewein L; Sadda SR; Sarraf D; Schwartz SD
    Retin Cases Brief Rep; 2015; 9(4):286-9. PubMed ID: 26288110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2.
    Toygar O; Guess MG; Youssef DS; Miller DM
    Retina; 2016 Nov; 36(11):2150-2157. PubMed ID: 27258671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S; Polat O; Karadas M; Inan UU
    Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
    [No Abstract]   [Full Text] [Related]  

  • 24. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical coherence tomography angiography findings of fellow eye of proliferative macular telangiectasia type 2: Long term study.
    Singh SR; Fraser-Bell S; Dogra A; Sahoo NK; Gabrielle PH; Lupidi M; Al-Sheikh M; Borrelli E; Sacconi R; Querques G; Chhablani J
    Eur J Ophthalmol; 2021 Jul; 31(4):1933-1939. PubMed ID: 32613846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Gune S; Abdelfattah NS; Karamat A; Balasubramanian S; Marion KM; Morgenthien E; Sadda SR
    Ophthalmology; 2020 Apr; 127(4):523-532. PubMed ID: 31718842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.
    Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R
    Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
    Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of multicolor imaging, its component channels, and fundus autofluorescence in describing macular telangiectasia type-2 (MacTel) lesion characteristics.
    Chandran K; Giridhar A; Desai S; Gopalakrishnan M; Indu VP; Sivaprasad S
    Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S125-S134. PubMed ID: 38131554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
    Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH
    Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic Correlation of Anti-Vascular Endothelial Growth Factor-Treated Type 3 Neovascularization in Age-Related Macular Degeneration.
    Li M; Dolz-Marco R; Messinger JD; Wang L; Feist RM; Girkin CA; Gattoussi S; Ferrara D; Curcio CA; Freund KB
    Ophthalmology; 2018 Feb; 125(2):276-287. PubMed ID: 28964579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
    Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
    Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal Morphology in Sjögren-Larsson Syndrome on OCT: From Metabolic Crystalline Maculopathy to Early-Onset Macular Degeneration.
    Staps P; Cruysberg JRM; Roeleveld N; Willemsen MAAP; Theelen T
    Ophthalmol Retina; 2019 Jun; 3(6):500-509. PubMed ID: 31174672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agreement of Spectral-Domain OCT with Fluorescein Leakage in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.
    Khurana RN; Hill L; Ghanekar A; Gune S
    Ophthalmol Retina; 2020 Nov; 4(11):1054-1058. PubMed ID: 32353536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
    Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
    Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescein angiography of subretinal neovascular membrane in parafoveal telangiectasia type II demonstrating retino-retinal, retino-subretinal anastomosis.
    Megur B; Megur D; Reddy S
    Indian J Ophthalmol; 2016 Nov; 64(11):840-842. PubMed ID: 27958208
    [No Abstract]   [Full Text] [Related]  

  • 38. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Swept source optical coherence tomography analysis of choroidal thickness in macular telangiectasia type 2: a case-control study.
    Kumar V; Kumawat D; Kumar P
    Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):567-573. PubMed ID: 30560414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HYPERREFLECTIVITY ON OPTICAL COHERENCE TOMOGRAPHY IN MACULAR TELANGIECTASIA TYPE 2.
    Tzaridis S; Hess K; Heeren TFC; Bonelli R; Holz FG; Friedlander M
    Retina; 2021 Jul; 41(7):1428-1437. PubMed ID: 33438900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.